Business Analysis Report
49 views | +0 today
Your new post is loading...
Your new post is loading...
Scooped by suresh kumar
Scoop.it!

Bile Duct Cancer Market- Clinical Trials Review

Bile Duct Cancer Market- Clinical Trials Review | Business Analysis Report | Scoop.it

Bile Duct Cancer (Cholangiocarcinoma) Global Clinical Trials Review, H1, 2014 is a market research report available at US $2500 for a Single User PDF License from RnR Market Research Reports Library.

suresh kumar's insight:

The Report “Bile Duct Cancer (Cholangiocarcinoma) Global Clinical Trials Review, H1, 2014″ by GlobalData is now available at RnRMarketResearch.com. Contact sales@rnrmarketresearch.com with “Bile Duct Cancer (Cholangiocarcinoma) Global Clinical Trials Review, H1, 2014″ in subject line and your contact details to purchase this report or get your questions answered.

“Bile Duct Cancer (Cholangiocarcinoma) Global Clinical Trials Review, H1, 2014″ provides data on the Bile Duct Cancer (Cholangiocarcinoma) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Bile Duct Cancer (Cholangiocarcinoma) . It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Bile Duct Cancer (Cholangiocarcinoma) . This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Researcher’s team of industry experts.

Request Sample copy of this report @ http://www.rnrmarketresearch.com/contacts/request-sample?rname=150323 .

Scope

Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nationsClinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor typeListings of discontinued trials (suspended, withdrawn and terminated)

Complete report is available @ http://www.rnrmarketresearch.com/bile-duct-cancer-cholangiocarcinoma-global-clinical-trials-review-h1-2014-market-report.html . Read more on “Bile Duct Cancer (Cholangiocarcinoma) Global Clinical Trials Review, H1, 2014” report below.

Reasons to buy

Understand the dynamics of a particular indication in a condensed mannerAbridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many moreObtain discontinued trial listing for trials across the globeEspy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

 

Table of Contents

Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Bile Duct Cancer (Cholangiocarcinoma) 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Bile Duct Cancer (Cholangiocarcinoma) to Oncology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Bile Duct Cancer (Cholangiocarcinoma) to Oncology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Bile Duct Cancer (Cholangiocarcinoma) 25
Subjects Recruited Over a Period of Time 30
Clinical Trials by Sponsor Type 31
Prominent Sponsors 32
Top Companies Participating in Bile Duct Cancer (Cholangiocarcinoma) Therapeutics Clinical Trials 33
Prominent Drugs 34
Latest Clinical Trials News on Bile Duct Cancer (Cholangiocarcinoma) 35
Jan 13, 2014: Concordia Healthcare announces FDA agreement on Special Protocol Assessment for Phase 3 Clinical trial on new therapy to treat perihilar cholangiocarcinoma 35
Aug 21, 2012: PCI Biotech To Start Phase I/II Study Using Amphinex For Treatment Of Bile Duct Cancer 35
Jan 10, 2012: Clinical Study Confirms Benitec's Gene-silencing Technology Is Safe And Effective In Fang Vaccine 36
Apr 07, 2009: Oncolytics Biotech Inc. Announces Positive Results of U.K. Phase II REOLYSIN and Radiation Combination Clinical Trial For The Trial REO 008 36
Nov 16, 2006: Helsinn To Discontinue Becatecarin Trial Program 37
Clinical Trial Profiles 38
Clinical Trial Overview of Top Companies 38
Eli Lilly and Company 38
Clinical Trial Overview of Eli Lilly and Company 38
Sanofi 39
Clinical Trial Overview of Sanofi 39
AstraZeneca PLC 40
Clinical Trial Overview of AstraZeneca PLC 40
GlaxoSmithKline plc 41
Clinical Trial Overview of GlaxoSmithKline plc 41
PCI Biotech AS 42
Clinical Trial Overview of PCI Biotech AS 42
Groupe Cooperateur Multidisciplinaire en Oncologie 43
Clinical Trial Overview of Groupe Cooperateur Multidisciplinaire en Oncologie 43
Daiichi Sankyo Company, Limited 44
Clinical Trial Overview of Daiichi Sankyo Company, Limited 44
CellAct Pharma GmbH 45
Clinical Trial Overview of CellAct Pharma GmbH 45
C. H. Boehringer Sohn AG & Co. KG 46
Clinical Trial Overview of C. H. Boehringer Sohn AG & Co. KG 46
Astellas US Holding, Inc. 47
Clinical Trial Overview of Astellas US Holding, Inc. 47
Clinical Trial Overview of Top Institutes / Government 48
National Cancer Institute 48
Clinical Trial Overview of National Cancer Institute 48
Kansai Hepatobiliary Oncology Group 51
Clinical Trial Overview of Kansai Hepatobiliary Oncology Group 51
Memorial Sloan Kettering Cancer Center 52
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 52
Massachusetts General Hospital 53
Clinical Trial Overview of Massachusetts General Hospital 53
Tohoku University 54
Clinical Trial Overview of Tohoku University 54
Roswell Park Cancer Institute 55
Clinical Trial Overview of Roswell Park Cancer Institute 55
Yokohama City University 56
Clinical Trial Overview of Yokohama City University 56
Chiba University 57
Clinical Trial Overview of Chiba University 57
National Cancer Center Hospital 58
Clinical Trial Overview of National Cancer Center Hospital 58
Washington University School of Medicine 59
Clinical Trial Overview of Washington University School of Medicine 59
Five Key Clinical Profiles 60
Appendix 88
Abbreviations 88
Definitions 88
Research Methodology 89
Secondary Research 89
Contact Us 90
Disclaimer 90
Source 91

For further information on “Bile Duct Cancer (Cholangiocarcinoma) Global Clinical Trials Review, H1, 2014” report OR for any other business research / market intelligence need on the ‘Clinical Trial’ market (http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/clinical-trial . ), contact sales@rnrmarketresearch.com / Call +1 888 391 5441.

About Us:

RnRMarketResearch.com is an online market research reports library of 250,000+ in-depth studies of over 5000 micro markets. Our database includes reports by leading publishers from across the globe. We provide 24/7 online and offline support service to our customers. RnR Market Research also offers company data, country profiles, trends, information and analysis on the sector of your interest.

 

You can also reach us @

http://rnrmarketresearch.blogspot.in/

http://www.rnrmarketresearch.com/blog/

http://www.facebook.com/pages/RnR-Market-Research/413488545356345

https://plus.google.com/u/0/104156468549256253075/

https://twitter.com/#!/RnRMR

http://www.dailymotion.com/rnrmarketresearch

http://www.youtube.com/user/rnrmarketresearch

http://www.slideshare.net/rnrmarketresearch3/

more...
No comment yet.
Scooped by suresh kumar
Scoop.it!

Hemangiomas Industry key Drugs Clinical Review

Hemangiomas Industry key Drugs Clinical Review | Business Analysis Report | Scoop.it
Hemangiomas Global Clinical Trials Review, H1, 2014 is a market research report available at US $2500 for a Single User PDF License from RnR Market Research Reports Library.
suresh kumar's insight:

The Report “Hemangiomas Global Clinical Trials Review, H1, 2014″ by GlobalData is now available at RnRMarketResearch.com. Contact sales@rnrmarketresearch.com with “Hemangiomas Global Clinical Trials Review, H1, 2014″ in subject line and your contact details to purchase this report or get your questions answered.

“Hemangiomas Global Clinical Trials Review, H1, 2014″ provides data on the Hemangiomas clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hemangiomas. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hemangiomas. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Researcher’s team of industry experts.

Request Sample copy of this report @ http://www.rnrmarketresearch.com/contacts/request-sample?rname=150317 .

Scope

Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nationsClinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor typeListings of discontinued trials (suspended, withdrawn and terminated)

Complete report is available @ http://www.rnrmarketresearch.com/hemangiomas-global-clinical-trials-review-h1-2014-market-report.html . Read more on “Hemangiomas Global Clinical Trials Review, H1, 2014” report below.

Reasons to buy

Understand the dynamics of a particular indication in a condensed mannerAbridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many moreObtain discontinued trial listing for trials across the globeEspy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Hemangiomas 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Hemangiomas to Dermatology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Hemangiomas to Dermatology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Hemangiomas 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Hemangiomas Therapeutics Clinical Trials 30
Prominent Drugs 31
Clinical Trial Profiles 32
Clinical Trial Overview of Top Companies 32
Laboratoires Pierre Fabre SA 32
Clinical Trial Overview of Laboratoires Pierre Fabre SA 32
MethylGene Inc. 33
Clinical Trial Overview of MethylGene Inc. 33
Maruho Co., Ltd. 34
Clinical Trial Overview of Maruho Co., Ltd. 34
InfectoPharm Arzneimittel und Consilium GmbH 35
Clinical Trial Overview of InfectoPharm Arzneimittel und Consilium GmbH 35
Clinical Trial Overview of Top Institutes / Government 36
Medical College of Wisconsin 36
Clinical Trial Overview of Medical College of Wisconsin 36
The University of New Mexico 37
Clinical Trial Overview of The University of New Mexico 37
The Hospital for Sick Children 38
Clinical Trial Overview of The Hospital for Sick Children 38
Keio University 39
Clinical Trial Overview of Keio University 39
The Ohio State University 40
Clinical Trial Overview of The Ohio State University 40
Southwest Hospital, China 41
Clinical Trial Overview of Southwest Hospital, China 41
Oregon Health and Science University 42
Clinical Trial Overview of Oregon Health and Science University 42
National Institute of Neurological Disorders and Stroke 43
Clinical Trial Overview of National Institute of Neurological Disorders and Stroke 43
Eastern Hepatobiliary Surgery Hospital 44
Clinical Trial Overview of Eastern Hepatobiliary Surgery Hospital 44
National Cancer Institute 45
Clinical Trial Overview of National Cancer Institute 45
Five Key Clinical Profiles 46
Appendix 74
Abbreviations 74
Definitions 74
Research Methodology 75
Secondary Research 75
Contact Us 76
Disclaimer 76
Source 76

 

For further information on “Hemangiomas Global Clinical Trials Review, H1, 2014” report OR for any other business research / market intelligence need on the ‘Clinical Trial’ market (http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/clinical-trial . ), contact sales@rnrmarketresearch.com / Call +1 888 391 5441.

 

About Us:

RnRMarketResearch.com is an online market research reports library of 250,000+ in-depth studies of over 5000 micro markets. Our database includes reports by leading publishers from across the globe. We provide 24/7 online and offline support service to our customers. RnR Market Research also offers company data, country profiles, trends, information and analysis on the sector of your interest.

 

You can also reach us @

http://rnrmarketresearch.blogspot.in/

http://www.rnrmarketresearch.com/blog/

http://www.facebook.com/pages/RnR-Market-Research/413488545356345

https://plus.google.com/u/0/104156468549256253075/

https://twitter.com/#!/RnRMR

http://www.dailymotion.com/rnrmarketresearch

http://www.youtube.com/user/rnrmarketresearch

http://www.slideshare.net/rnrmarketresearch3/

more...
No comment yet.
Scooped by suresh kumar
Scoop.it!

Immunodiagnostics & Clinical Chemistry Market Report 2014

Immunodiagnostics & Clinical Chemistry Market Report 2014 | Business Analysis Report | Scoop.it
[521 Pages Report] Check for Discount on Italian Hospital Clinical Chemistry and Immunodiagnostics Market 2014 report by Venture Planning Group. This new report from Venture Planning Group contains 521 pag...
suresh kumar's insight:
Order report “Italian Hospital Clinical Chemistry and Immunodiagnostics Market 2014” by calling ReportsnReports.com at +1 888 391 5441 OR send an email on sales@reportsandreports.com with Italian Hospital Clinical Chemistry and Immunodiagnostics Market 2014 in subject line and your contact details. 

This new report contains 521 pages, 63 tables, and presents a comprehensive analysis of the Italian hospital clinical chemistry and immunodiagnostics market, including:

Major issues pertaining to the Italian clinical chemistry and immunodiagnostic hospital laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.

Five-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in Italian hospitals, including controls, calibrators and consumables.

Five-year volume forecasts for serum, whole blood, plasma, CFS, urine and other specimens.

Five-year reagent and instrument sales forecasts.

Review of current instrumentation technologies, and a feature comparison
of high-, medium-, and low-volume/POC analyzers.

 

Complete report is spread across 521 pages is available @ http://www.reportsnreports.com/reports/274104-italian-hospital-clinical-chemistry-and-immunodiagnostics-market-2014.html .

Sales and market shares of leading reagent and instrument suppliers.

Review of current and emerging technologies and their potential market applications.

Product development opportunities for clinical chemistry and immunodiagnostic instruments and consumables.

Profiles of current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.

Market penetration strategies, entry barriers and risks.

 

Buy a copy of report @

http://www.reportsnreports.com/purchase.aspx?name=274104 .

 

 Table of Contents
Introduction


Worldwide Market and Technology Overview
A. Major Routine Chemistry Tests

B. Therapeutic Drug Monitoring (TDM)


C. Endocrine Function Tests

D. Tumor Markers And Special Chemistry Tests

E. Immunoprotein Tests

F. Drugs of Abuse

G. Instrumentation Review: Operating Characteristics and Features of High, Medium, and Low Volume/POC

H. Major In Vitro Diagnostic Technologies and Their Potential Applications

Italy

A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Suppliers’ Instrument and Reagent Sales and Market Shares
Major Product Development Opportunities
Design Criteria for Decentralized Testing Products
Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
Competitive Assessments
Abbott Laboratories AdnaGen
Beckman Coulter/Danaher
Biomedical Diagnostics
BioMerieux
BioRad
Dako
DiaSorin
Eiken
Fujirebio Instrumentation Laboratory
Kyowa Medex
Matritech
OrthoClinical Diagnostics
Roche
Siemens
Sysmex
Thermo Fisher
Tosoh
Wako
Wallac/PE

Contact sales@reportsandreports.com / Call +1 888 391 5441 for further information on “Italian Hospital Clinical Chemistry and Immunodiagnostics Market 2014” report OR for any other market research and intelligence needs you may have for your business.

For more detail visit: http://www.studymode.com/essays/Clinical-Chemistry-Immunodiagnostics-Industry-Forecasts-46745217.html .

more...
No comment yet.
Scooped by suresh kumar
Scoop.it!

China Market Reports China Industry Market Research Reports | LinkedIn

China Market Reports China Industry Market Research Reports | LinkedIn | Business Analysis Report | Scoop.it
View China Market Reports China Industry Market Research Reports's professional profile on LinkedIn.
more...
No comment yet.
Scooped by suresh kumar
Scoop.it!

Master Oil & Oil Burner Co Builders & Contractors 1 Of 2 in 19138 Philadelphia, PA

Master Oil & Oil Burner Co Builders & Contractors 1 Of 2 in 19138 Philadelphia, PA | Business Analysis Report | Scoop.it
All about Master Oil & Oil Burner Co Builders & Contractors 1 Of 2 in 19138 Philadelphia, PA with their information, reviews, business address, contact and more.
more...
No comment yet.
Scooped by suresh kumar
Scoop.it!

Bhubaneswar - Wikipedia, the free encyclopedia

Bhubaneswar - Wikipedia, the free encyclopedia

Bhubaneswar is located in Khordha district of Odisha. It is situated in the eastern coastal plains, along the axis of the Eastern Ghats mountains. The city has an average altitude of 45 m (148 ft) above sea level. It lies southwest of the Mahanadi River that forms the northern boundary of Bhubaneswar metropolitan area, within its delta.

more...
No comment yet.
Scooped by suresh kumar
Scoop.it!

Regional Consumer Goods Market Research Reports at MarketOptimizer.org

Consumer Goods market research reports on global and regional industries by leading publishers covering market trends, size, share and other business intelligence information are available with MarketOptimizer.org.
more...
No comment yet.
Scooped by suresh kumar
Scoop.it!

Regional Life Sciences Market Research Reports at MarketOptimizer.org

Life Sciences market research reports on global and regional industries by leading publishers covering market trends, size, share and other business intelligence information are available with MarketOptimizer.org.
more...
No comment yet.
Scooped by suresh kumar
Scoop.it!

Orisha - Wikipedia, the free encyclopedia

Orisha

An Orisha (also spelled Orisa or Orixa) is a spirit or deity that reflects one of the manifestations of God in the Yoruba spiritual or religious system. This religion has found its way throughout the world and is now expressed in practices as varied as Santería, Candomblé, Trinidad Orisha, Anago and Oyotunji, as well as in some aspects of Umbanda, Winti, Obeah, Vodun and a host of others.

more...
No comment yet.
Scooped by suresh kumar
Scoop.it!

Real Estate Software Market: 2018 Trends, Vendor and Growth Drivers Analysis in New Research Report

Real Estate Software Market: 2018 Trends, Vendor and Growth Drivers Analysis in New Research Report | Business Analysis Report | Scoop.it
Global Real Estate Software Market 2014-2018: Order report by calling ReportsnReports.com at +1 888 391 5441 with (Real Estate Software Market) in subject line and your contact details.
more...
No comment yet.
Scooped by suresh kumar
Scoop.it!

Basal Cell Carcinoma Market- Clinical Trials Review

Basal Cell Carcinoma Market- Clinical Trials Review | Business Analysis Report | Scoop.it

Basal Cell Carcinoma (Basal Cell Epithelioma) Global Clinical Trials Review, H1, 2014 is a market research report available at US $2500 for a Single User PDF License from RnR Market Research Reports Library.

suresh kumar's insight:

The Report “Basal Cell Carcinoma (Basal Cell Epithelioma) Global Clinical Trials Review, H1, 2014″ by GlobalData is now available at RnRMarketResearch.com. Contact sales@rnrmarketresearch.com with “Basal Cell Carcinoma (Basal Cell Epithelioma) Global Clinical Trials Review, H1, 2014″ in subject line and your contact details to purchase this report or get your questions answered.

“Basal Cell Carcinoma (Basal Cell Epithelioma) Global Clinical Trials Review, H1, 2014″ provides data on the Basal Cell Carcinoma (Basal Cell Epithelioma) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Basal Cell Carcinoma (Basal Cell Epithelioma) . It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Basal Cell Carcinoma (Basal Cell Epithelioma) . This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Researcher’s team of industry experts.

Request Sample copy of this report @ http://www.rnrmarketresearch.com/contacts/request-sample?rname=150322 .

Scope

Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nationsClinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor typeListings of discontinued trials (suspended, withdrawn and terminated)

Complete report is available @ http://www.rnrmarketresearch.com/basal-cell-carcinoma-basal-cell-epithelioma-global-clinical-trials-review-h1-2014-market-report.html  . Read more on “Basal Cell Carcinoma (Basal Cell Epithelioma) Global Clinical Trials Review, H1, 2014” report below.

Reasons to buy

Understand the dynamics of a particular indication in a condensed mannerAbridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many moreObtain discontinued trial listing for trials across the globeEspy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

Table of Contents 2
List of Tables 4
List of Figures 6
Introduction 7
Basal Cell Carcinoma (Basal Cell Epithelioma) 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials and Average Enrollment by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Five Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by G7 Countries: Proportion of Basal Cell Carcinoma (Basal Cell Epithelioma) to Oncology Clinical Trials 16
Clinical Trials by Phase in G7 Countries 17
Clinical Trials in G7 Countries by Trial Status 18
Clinical Trials by E7 Countries: Proportion of Basal Cell Carcinoma (Basal Cell Epithelioma) to Oncology Clinical Trials 19
Clinical Trials by Phase in E7 Countries 20
Clinical Trials in E7 Countries by Trial Status 21
Clinical Trials by Phase 22
In Progress Trials by Phase 23
Clinical Trials by Trial Status 24
Clinical Trials by End Point Status 25
Unaccomplished Trials of Basal Cell Carcinoma (Basal Cell Epithelioma) 26
Subjects Recruited Over a Period of Time 28
Clinical Trials by Sponsor Type 29
Prominent Sponsors 30
Top Companies Participating in Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Clinical Trials 31
Prominent Drugs 32
Latest Clinical Trials News on Basal Cell Carcinoma (Basal Cell Epithelioma) 33
Sep 24, 2012: Cannabis Science Initiates Preclinical Investigation Of CS-TATI-1 For European Studies For Squamous/Basal Cell Carcinomas And Kaposi's Sarcoma 33
Jun 20, 2011: Roche Reports Positive Results From Phase II Study Of Carcinoma Drug 33
Mar 21, 2011: Curis Announces Positive Results In Genentech Pivotal Phase II Clinical Trial Of GDC-0449 In Advanced Basal Cell Carcinoma 34
Apr 16, 2008: Graceway pharmaceuticals reports study in British Journal of Dermatology 35
Jul 17, 2006: Results Of Nodular Basal Cell Carcinoma Clinical Trial 36
Clinical Trial Profiles 38
Clinical Trial Overview of Top Companies 38
F. Hoffmann-La Roche Ltd. 38
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 38
Novartis AG 40
Clinical Trial Overview of Novartis AG 40
Galderma S.A. 41
Clinical Trial Overview of Galderma S.A. 41
Peplin Inc. (Inactive) 42
Clinical Trial Overview of Peplin Inc. (Inactive) 42
Meda AB 43
Clinical Trial Overview of Meda AB 43
Graceway Pharmaceuticals, LLC 44
Clinical Trial Overview of Graceway Pharmaceuticals, LLC 44
Bristol-Myers Squibb Company 45
Clinical Trial Overview of Bristol-Myers Squibb Company 45
Curis, Inc. 46
Clinical Trial Overview of Curis, Inc. 46
Biofrontera Bioscience GmbH 47
Clinical Trial Overview of Biofrontera Bioscience GmbH 47
Berg Pharma, LLC 48
Clinical Trial Overview of Berg Pharma, LLC 48
Clinical Trial Overview of Top Institutes / Government 49
National Cancer Institute 49
Clinical Trial Overview of National Cancer Institute 49
Maastricht University Medical Center 51
Clinical Trial Overview of Maastricht University Medical Center 51
Roswell Park Cancer Institute 52
Clinical Trial Overview of Roswell Park Cancer Institute 52
Norwegian University of Science and Technology 53
Clinical Trial Overview of Norwegian University of Science and Technology 53
Stanford University 54
Clinical Trial Overview of Stanford University 54
University Hospital Tubingen 55
Clinical Trial Overview of University Hospital Tubingen 55
Northwestern University 56
Clinical Trial Overview of Northwestern University 56
Mayo Clinic 57
Clinical Trial Overview of Mayo Clinic 57
Shahid Beheshti University of Medical Sciences 58
Clinical Trial Overview of Shahid Beheshti University of Medical Sciences 58
Center for Genetic Engineering and Biotechnology 59
Clinical Trial Overview of Center for Genetic Engineering and Biotechnology 59
Five Key Clinical Profiles 60
Appendix 89
Abbreviations 89
Definitions 89
Research Methodology 90
Secondary Research 90
Contact Us 91
Disclaimer 91
Source 92

 

For further information on “Basal Cell Carcinoma (Basal Cell Epithelioma) Global Clinical Trials Review, H1, 2014” report OR for any other business research / market intelligence need on the ‘Clinical Trial’ market (http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/clinical-trial .), contact sales@rnrmarketresearch.com / Call +1 888 391 5441.

 

About Us:

RnRMarketResearch.com is an online market research reports library of 250,000+ in-depth studies of over 5000 micro markets. Our database includes reports by leading publishers from across the globe. We provide 24/7 online and offline support service to our customers. RnR Market Research also offers company data, country profiles, trends, information and analysis on the sector of your interest.

 

You can also reach us @

http://rnrmarketresearch.blogspot.in/

http://www.rnrmarketresearch.com/blog/

http://www.facebook.com/pages/RnR-Market-Research/413488545356345

https://plus.google.com/u/0/104156468549256253075/

https://twitter.com/#!/RnRMR

http://www.dailymotion.com/rnrmarketresearch

http://www.youtube.com/user/rnrmarketresearch

http://www.slideshare.net/rnrmarketresearch3/

more...
No comment yet.
Scooped by suresh kumar
Scoop.it!

Russia Orthopedic Tools Market Forecast to 2020

Russia Orthopedic Tools Market Forecast to 2020 | Business Analysis Report | Scoop.it
Russia Orthopedic Tools Market Outlook to 2020 is a market research report available at US $2500 for a Single User PDF License from RnR Market Research Reports Library.
suresh kumar's insight:

The Report “Russia Orthopedic Tools Market Outlook to 2020″ by GlobalData is now available at RnRMarketResearch.com. Contact sales@rnrmarketresearch.com with “Russia Orthopedic Tools Market Outlook to 2020″ in subject line and your contact details to purchase this report or get your questions answered.

“Russia Orthopedic Tools Market Outlook to 2020″, provides key market data on the Russia Orthopedic Tools market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories Orthopedic Power Tools and Orthopedic Reamers.

The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Orthopedic Tools market wherever available.

The data in the report is derived from dynamic market forecast models. Researcher uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Request Sample copy of this report @ http://www.rnrmarketresearch.com/contacts/request-sample?rname=149062 .

Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Complete report is available @ http://www.rnrmarketresearch.com/russia-orthopedic-tools-market-outlook-to-2020-market-report.html .Read more on “Russia Orthopedic Tools Market Outlook to 2020” report below.

Scope

Market size for Orthopedic Tools market categories Orthopedic Power Tools and Orthopedic Reamers.Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2005 to 2012 and forecast to 2020.2012 company shares and distribution shares data for each of the market categories.Global corporate-level profiles of key companies operating within the Russia Orthopedic Tools market.Key players covered include Stryker Corporation, DePuy Companies, B. Braun Melsungen AG and Smith & Nephew Plc

Reasons to buy

Develop business strategies by identifying the key market segments poised for strong growth in the future.Develop market-entry and market expansion strategies.Design competition strategies by identifying who-stands-where in the market.Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.What are the key distribution channels and what’s the most preferred mode of product distribution Identify, understand and capitalize.

For further information on “Russia Orthopedic Tools Market Outlook to 2020” report OR for any other business research / market intelligence need on the ‘Orthopedic Device’ market (http://www.rnrmarketresearch.com/reports/life-sciences/medical-devices/orthopedic-device . ), contact sales@rnrmarketresearch.com / Call +1 888 391 5441.

 

About Us:

RnRMarketResearch.com is an online market research reports library of 250,000+ in-depth studies of over 5000 micro markets. Our database includes reports by leading publishers from across the globe. We provide 24/7 online and offline support service to our customers. RnR Market Research also offers company data, country profiles, trends, information and analysis on the sector of your interest.

 

You can also reach us @

http://rnrmarketresearch.blogspot.in/

http://www.rnrmarketresearch.com/blog/

http://www.facebook.com/pages/RnR-Market-Research/413488545356345

https://plus.google.com/u/0/104156468549256253075/

https://twitter.com/#!/RnRMR

http://www.dailymotion.com/rnrmarketresearch

http://www.youtube.com/user/rnrmarketresearch

http://www.slideshare.net/rnrmarketresearch3/

more...
No comment yet.
Scooped by suresh kumar
Scoop.it!

New Report on Diabetic Neuropathy & Epidemiology Forecast to 2022

New Report on Diabetic Neuropathy & Epidemiology Forecast to 2022 | Business Analysis Report | Scoop.it
Buy the report "EpiCast Report: Diabetic Neuropathy - Epidemiology Forecast to 2022" at US $3995 for a Single User PDF License from RnR Market Research Reports Library.
suresh kumar's insight:
The report “EpiCast Report: Diabetic Neuropathy – Epidemiology Forecast to 2022″ by Canadean is now available at RnRMarketResearch.com. Contact sales@rnrmarketresearch.com with EpiCast Report: Diabetic Neuropathy – Epidemiology Forecast to 2022 in subject line and your contact details to purchase this report or get your questions answered 

The collection of “Diabetes Therapeutics” market research reports has a new addition of “EpiCast Report: Diabetic Neuropathy – Epidemiology Forecast to 2022” on RnRMarketResearch.com

Diabetic neuropathy affects an estimated 50% of patients with diabetes and is one of the leading causes of morbidity in diabetic patients, often leading to foot ulcerations or amputation. Diabetic neuropathy is clinically defined as “the presence of symptoms and/or signs of peripheral nerve dysfunction in people with diabetes after the exclusion of other causes” (Argoff et al., 2006; Boulton et al., 1998).

 

According to the epidemiologic literature, poor glycemic control, age, duration of diabetes, and obesity are risk factors for diabetic neuropathy (Abbott et al., 2011; Adler et al., 1997; Argoff et al., 2006; Tesfaye and Selvarajah, 2012). However, diabetic neuropathy is considered to be part of the natural progression of diabetes as a microvascular complication of the disease.

 

 Request a sample copy of this report by GlobalData @

http://www.rnrmarketresearch.com/contacts/request-sample?rname=135650 .

 

GlobalData epidemiologists forecast that the total prevalent cases of diabetic neuropathy in the diagnosed diabetic population in the seven major markets (7MM) (US, France, Germany, Italy, Spain, UK, and Japan) will increase from 13,842,033 cases in 2012 to 19,783,289 cases in 2022 at an Annual Growth Rate (AGR) of 4.29%. Throughout the forecast period, the US will have the highest number of total prevalent diabetic neuropathy cases in the diagnosed diabetic population, with approximately 45% of the cases. The increase in the number of total prevalent cases of diabetic neuropathy in the 7MM is the result of changing population demographics and GlobalData’s predicted increase in the diagnosed prevalent cases of diabetes in the 7MM.

 Inquire for a discount on this report by GlobalData @ http://www.rnrmarketresearch.com/contacts/discount?rname=135650 .  

Scope

The diabetic neuropathy EpiCast Report provides an overview of the risk factors and epidemiological trends for diabetic neuropathy in the seven major markets (6MM) (US, France, Germany, Italy, Spain, and UK). It includes a 10-year epidemiological forecast of the total prevalent cases of diabetic neuropathy in the diagnosed diabetic population segmented by age, (adults over the age of 40 years), sex, and the proportion of comorbid hypertension prevalent case in these markets.The diabetic neuropathy epidemiology report is written and developed by Mastersand PhD-level epidemiologists.The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 7MM.

 

Purchase a copy of this report by GlobalData @ http://www.rnrmarketresearch.com/contacts/purchase?rname=135650 .

 

Reasons to buy

Develop business strategies by understanding the trends shaping and driving the global DFU market.Quantify patient populations in the global diabetic neuropathy market to improve product design, pricing, and launch plans.Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for diabetic neuropathy therapeutics in each of the markets covered. Complete report spread across having Table of Contents available @ http://www.rnrmarketresearch.com/epicast-report-diabetic-neuropathy-epidemiology-forecast-to-2022-market-report.html

Table of Contents

 

1 Table of Contents 4
1.1 List of Tables 5
1.2 List of Figures 6

 

2 Introduction 7
2.1 Catalyst 7

 

3 Epidemiology 8
3.1 Disease Background 8
3.2 Risk Factors and Comorbidities 9
3.3 Global Trends 9
3.3.1 US 10
3.3.2 5EU 11
3.3.3 Japan 12
3.4 Epidemiological Forecast for Diabetic Neuropathy (2012-2022) 13
3.4.1 Forecast Methodology 13
3.4.2 Sources Used 14
3.4.3 Sources Not Used 17
3.4.4 Forecast Assumptions and Methods — Diagnosed Prevalent Cases of Diabetes 19
3.4.5 Forecast Assumptions and Methods — Diabetic Neuropathy 23
3.5 Epidemiology Forecast for Diabetic Neuropathy (2012-2022) 25
3.5.1 Diabetic Neuropathy 25
3.5.2 Total Prevalent Cases of Diabetic Neuropathy by Age 27
3.5.3 Total Prevalent Cases of Diabetic Neuropathy by Sex 29
3.5.4 Total Prevalent Cases of Diabetic Neuropathy, Comorbid Hypertension 31
3.6 Discussion 32
3.6.1 Conclusions on Epidemiological Trends 32
3.6.2 Limitations of the Analysis 34
3.6.3 Strengths of the Analysis 35

 

4 Appendix 36
4.1 Bibliography 36
4.2 About the Authors 41
4.2.1 Epidemiologists 41
4.2.2 Reviewers 41
4.2.3 Global Director of Epidemiology and Health Policy 42
4.2.4 Global Head of Healthcare 42
4.3 About GlobalData 43
4.4 About EpiCast 43
4.5 Disclaimer 43

 

 

For further information on “EpiCast Report: Diabetic Neuropathy – Epidemiology Forecast to 2022” report OR for any other business research need on the Diabetes Therapeutics (http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/therapeutics/diabetes-therapeutics .), contact sales@rnrmarketresearch.com / Call +1 888 391 5441

For more detail visit: http://www.studymode.com/essays/Diabetic-Neuropathy-Epidemiology-Forecast-Report-Of-2022-46715250.html .

 
more...
No comment yet.
Scooped by suresh kumar
Scoop.it!

Global and China Stainless Steel Tableware and Kitchenware Industry Report, 2013-2015 by Research In China at China Market Research Reports

Global and China Stainless Steel Tableware and Kitchenware Industry Report, 2013-2015 by Research In China at China Market Research Reports | Business Analysis Report | Scoop.it
Global and China Stainless Steel Tableware and Kitchenware Industry Report, 2013-2015 published in Aug 2013 Available for US $ 1500 at ChinaMarketResearchReports.com - Buy Now or Inquire about this report online.
more...
No comment yet.
Scooped by suresh kumar
Scoop.it!

Research Report on China's Asset Securitization, 2013-2017 by China Research and Intelligence at China Market Research Reports

Research Report on China's Asset Securitization, 2013-2017 by China Research and Intelligence at China Market Research Reports | Business Analysis Report | Scoop.it
Research Report on China's Asset Securitization, 2013-2017 published in Jun 2013 Available for US $ 2800 at ChinaMarketResearchReports.com - Buy Now or Inquire about this report online.
more...
No comment yet.
Scooped by suresh kumar
Scoop.it!

Regional Food & Beverage Market Research Reports at MarketOptimizer.org

Food & Beverage market research reports on global and regional industries by leading publishers covering market trends, size, share and other business intelligence information are available with MarketOptimizer.org.
more...
No comment yet.
Scooped by suresh kumar
Scoop.it!

Regional IT & Telecomm Market Research Reports at MarketOptimizer.org

IT & Telecomm market research reports on global and regional industries by leading publishers covering market trends, size, share and other business intelligence information are available with MarketOptimizer.org.
more...
No comment yet.
Scooped by suresh kumar
Scoop.it!

Balasore - Wikipedia, the free encyclopedia

Balasore - Wikipedia, the free encyclopedia

With the creation of Bihar Province, Odisha was diverted along with Balasore district from Bengal to Bihar. But with the creation of Odisha as a separate State on 1 April 1936 Balasore became an integral part of Odisha State. The national movement of independence surged ahead with the visit of Mahatma Gandhi in 1921.

more...
No comment yet.
Scooped by suresh kumar
Scoop.it!

New Released: China Environmental Protection Equipment Market Report, 2013 - 2015

I'm reading Originated in 1973, China’s environmental protection industry witnessed rapid development in the period of "Eleventh Five-Year" (1996-2010) and "Twelfth Five-Year" (2011-2015) after experiencing the initial phase in 1980s and the...
more...
No comment yet.
Scooped by suresh kumar
Scoop.it!

China Environmental Protection Equipment Industry Report, 2013-2015 by Research In China at China Market Research Reports

China Environmental Protection Equipment Industry Report, 2013-2015 by Research In China at China Market Research Reports | Business Analysis Report | Scoop.it
China Environmental Protection Equipment Industry Report, 2013-2015 published in Jan 2014 Available for US $ 2200 at ChinaMarketResearchReports.com - Buy Now or Inquire about this report online.
more...
No comment yet.